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1. Introduction
Bariatric surgery has undergone a revolution since its inception in the 1960’s. Great strides
have been made in technique, safety and outcomes within the past decade and in the face of
the advent of newer procedures. This speaks to a better organization of bariatric surgery as a
specialty, improved training and the unwavering demand and pursuit of excellence. Despite
substantial improvement within the specialty there are a number of comorbid conditions and
preoperative findings revealed that necessitate optimization to obtain the best surgical
outcomes.
The ultimate goal of bariatric surgery should be to achieve, in as safe a manner as possible,
weight loss for the reduction in comorbid conditions and overall long-term effect on mortality
and quality of life. A significant contribution to this task has been a more thorough under‐
standing of obesity-related comorbidities and their effects on patient outcomes with respect
to perioperative morbidity and mortality. The evaluation of different comorbid conditions
through large patient databases has elucidated which comorbid factors contribute towards
perioperative morbidity and mortality.
The goal of this chapter will be to review the preoperative evaluation of patients preparing for
weight loss surgery. An overview of the general concepts will be described, and then a detailed
discussion of the more common comorbid conditions will be presented, along with relevant
points and recent literature to support the recommendations. We will utilize an organ system
approach. The strategy and rationale for the evaluations that are recommended (or not) will
be discussed. Their impact on outcomes will be elucidated for the reader to understand and
use to appropriately assess the patient preparing for surgery. An evidence-based approach
will show us how to maximize our evaluations of these patients. Awareness of these details
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
empowers healthcare providers to choose and counsel patients appropriately in the preoper‐
ative setting.
Weight loss surgery has been shown to have a significant impact on the lives of our patients.
Yet, we still face the issue of effectively evaluating and optimizing these patients in the
preoperative setting to allow them to partake of the benefits that await them on the other side.
The following preoperative evaluations will be addressed in the chapter: indications, cardio‐
vascular, vascular (venous system), pulmonary, endocrine, gastrointestinal, nutritional,
psychological, education, functional status. The significance of the final evaluation by the
anesthesiologist will also be discussed. Irrespective of the procedure chosen (gastric bypass,
gastric bypass, sleeve gastrectomy, duodenal switch), approach used (laparoscopic or open)
the preoperative evaluation is essential to prepare the patient for this major lifestyle change.
2. Indications
In 1991 the National Institutes of Health published a consensus statement regarding weight
loss surgery. Surgery was indicated in patients with a BMI ≥ 40 kg/m2 and in patients with a
BMI between 35 and 40 if they also had comorbidities. Severe sleep apnea, Pickwickian
syndrome, obesity related cardiomyopathy, severe diabetes mellitus and lifestyle limitations
were all considered comorbidities that would allow the patient to pursue surgery [1]. Since
1991 significant strides have been made in the field of weight loss surgery. It has since been
proven to be a method for sustained weight loss and resolution of comorbid conditions. As
the benefits to surgery continually develop, movements to change the indications to allow for
more patients to achieve the benefits of weight loss have been published. In 2009, recommen‐
dations were made to expand the indications to both adolescent (12 – 18 years old) and elderly
(>65 years old) patients [2].
For patients with a BMI ≥ 40 kg/m2, surgery is indicated for ages 19 – 64, even without comorbid
conditions. Adolescents with a BMI ≥ 40 kg/m2 must have prediabetes, diabetes with Hgb
A1c > 9, regardless of therapy or 7-9 on maximal medical therapy, severe hypertension (SBP >
140 and DBP > 90), hyperlipidemia, any degree of sleep apnea or joint pain interfering with
daily life in order to qualify for surgery. Elderly patients with BMI ≥ 40, like adolescents, require
comorbid conditions to qualify for surgery. The presence of diabetes with Hgb A1c > 9,
regardless of therapy or 7-9 on maximal medical therapy, hypertension, hyperlipidemia,
moderate to severe sleep apnea, venous stasis, or severe chronic joint pain would indicate the
need for weight loss surgery.
Patients with a BMI 35 – 39 kg/m2 and aged 19 – 64 should be recommended for surgery as
outlined in the 1991 NIH consensus statement. For adolescents in this BMI range diabetes with
Hgb A1c > 7, refractory severe hypertension or moderate to severe sleep apnea are required to
proceed with surgery. In the elderly population with BMI 35 – 39 kg/m2, diabetes with Hgb
A1c > 9, regardless of therapy or 7-9 on maximal medical therapy, refractory hypertension, and
moderate to severe sleep apnea are all criterion which support proceeding to surgery.
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Around the world, the indications for surgery differ based on the populations and prevalence
of obesity related comorbidities. In Europe, the guidelines allow for surgery in patients with
a BMI ≥40 kg/m2, BMI ≥ 35 kg/m2 with severe comorbidities, BMI 30-35 kg/m2 with diabetes,
in adolescents if BMI ≥ 40 kg/m2 and in the elderly with a favorable risk to benefit profile [3].
In the Asian population, the visceral fat percentage is higher than in Caucasian persons [4].
Asian persons also have a higher risk of developing diabetes mellitus, hypertension and
hyperlipidemia at a lower BMI relative to persons of other ethnicities. These factors support
the guidelines in Asia where surgery is recommended for all patients with a BMI ≥ 35 kg/m2.
Surgery is also considered for patients with a BMI > 30 kg/m2 with diabetes mellitus or
metabolic syndrome and inability to control with lifestyle alterations or medications [5].
3. Cardiovascular
Obesity has a negative effect on cardiovascular health. The presence of obesity increases the
risk for coronary artery disease, heart failure, cardiomyopathy, atrial fibrillation and hyper‐
tension [6]. All of these conditions, if not optimized, can lead to poor surgical outcomes in
bariatric surgery patients.
The approach to perioperative cardiovascular evaluation for non-cardiac surgery has been
extensively studied. The general principle to follow is that intervention is rarely needed in
order to lower risk unless it is indicated irrespective of the perioperative context [7]. There are
clinical predictors which place patients into categories based on risk of perioperative cardiac
events. Major predictors are unstable coronary syndromes, acute or recent myocardial
infarction with ongoing ischemic risk factors, unstable or severe angina, decompensated heart
failure, significant arrhythmias, high-grade atrio-ventricular blocks, certain arrhythmias and
severe valvular disease. Intermediate predictors include mild angina pectoris, previous
myocardial infarctions, compensated or prior heart failure, diabetes mellitus and renal
insufficiency. Minor predictors are advanced age, abnormal ECG, rhythm other than sinus,
low functional capacity, uncontrolled systemic hypertension and previous stroke. The type of
surgery is also associated with cardiac risk. Bariatric surgery is considered an intermediate
risk procedure.
Hypertension is found in 13.8 to 25.7 percent of obese patients [8,9]. In patients with stage
three hypertension, systolic blood pressure ≥180 mm Hg and a diastolic blood pressure ≥
110  mm  Hg,  the  risk  of  proceeding  with  surgery  must  be  evaluated  [7].  Presence  of
hypertension as  a  comorbidity  is  an independent  risk  factor  for  mortality  after  open or
laparoscopic gastric  bypass with an odds ratio of  2.783 [10].  Treatment with beta block‐
ers has been shown to decrease the risk of myocardial infarction and cardiovascular death
in high risk patients [11]. When indicated, beta blockers should be initiated several weeks
prior to surgery and titrated to achieve a resting heart rate of 50 to 60 beats per minute
[12]. As bariatric surgery is an elective procedure, we recommend delaying surgery until
adequate  blood  pressure  control  is  achieved.  Hypertension  should  be  controlled  before
surgery  with  continuation  of  the  preoperative  antihypertensive  treatment  through  the
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perioperative period [7]. Caution is advised when preparing a patient taking clonidine or
beta blockers for surgery, due to known rebound hypertension upon abrupt discontinua‐
tion. These antihypertensive agents may be converted to transdermal or intravenous forms,
respectively, during the time a patient is nil per os (NPO)[11]. Continuation of beta blockers
through the perioperative period is recommended in those patients being treated for angina,
specific  arrhythmias,  hypertension  and  other  American  College  of  Cardiology  (ACC)/
American Heart Association (AHA) Class 1 guideline indications [7].
The myriad of available tests to assess cardiac function can be overwhelming and choosing
which test to order can be confusing. Generally evaluation begins with a 12-lead electrocar‐
diogram (ECG). In bariatric surgery patients ECG abnormalities can uncover predictors of
perioperative and long term cardiovascular risk. ECG is recommended in all patients who
have had a recent episode of chest pain, asymptomatic patients with diabetes mellitus, patients
with prior coronary revascularization, asymptomatic males over 45 years old or females over
55 years old with two or more atherosclerotic risk factors and those patients who have had
prior hospital admissions for cardiac causes [7]. Further evaluation of cardiac function involves
stress testing and coronary angiography. Both methods are geared towards identifying
patients with cardiac ischemia.
Exercise or pharmacological stress testing is recommended in adult patients with intermediate
pretest probability of coronary artery disease based on ECG, those undergoing initial evalua‐
tion for suspected or proven coronary artery disease and patients with a significant change in
clinical status. Exercise testing is also useful to evaluate exercise capacity when subjective
measures are unreliable [7]. Some patients will not tolerate an exercise stress test. In this group
of patients a pharmacological stress test should be considered. Noninvasive cardiac imaging
without the use of pharmacological stressing agents is able to provide visualization of left
ventricular function at rest. Although this test is commonly done during preoperative
evaluations it is not a consistent predictor of perioperative ischemic events. Non-invasive stress
testing, such as a dobutamine stress echocardiogram, is able to predict perioperative cardiac
events by visualizing the amount of myocardium at risk for ischemia [7]. It has been shown,
however, that the accuracy of thallium-201 nuclear cardiac imaging can be diminished in
patients who have a BMI over 30 kg/m2, which is specific to our patient population [13]. There
is mounting evidence that cardiac computed tomography angiogram can be used as a method
to evaluate the coronary vasculature in patients unable to tolerate exercise prior to invasive
imaging procedures [14].
Coronary angiography is the definitive test for intraluminal causes of cardiac ischemia. The
procedure is diagnostic and can also be therapeutic with the usage of balloon angioplasty with
or without stent placement. Coronary angioplasty should be done on patients with suspected
or known coronary artery disease. These patients have a high risk of adverse outcome based
on noninvasive test results, angina unresponsive to adequate medical therapy or unstable
angina [7]. Percutaneous coronary intervention (PCI) does not decrease the risk of periopera‐
tive cardiac events except in those patients in whom PCI is indicated for acute coronary
syndrome. Although the PCI can reduce perioperative cardiac events, one of the major
limitations of treatment is the subsequent delay in surgery due to the direct mechanical effects
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of angioplasty or the required anti platelet therapy. Patients who undergo PCI with balloon
therapy alone should undergo surgery between four and eight weeks after catheterization.
Before four weeks the dilated blood vessels have not fully healed and after eight weeks the
risk of restenosis is high [7].
Cardiac medications after coronary artery stenting present a controversy for the surgeon as
the drugs increase the risk of bleeding during the perioperative period. Stent placement
requires dual anti platelet therapy with clopidogrel and aspirin in the post PCI period to
prevent stent thrombosis. The American College of Cardiology and The American Heart
Association recommend that dual anti platelet treatment is required for at least one month in
patients receiving bare metal stents and for one year with drug eluting stents [7]. In a literature
review currently in press, the authors examined the perioperative management of anti platelet
therapy and they found variability among the recommendations. However, they recommend
delaying surgery for at least four to twelve weeks in patients with bare metal stents. In patients
with drug eluting stents they recommend postponing surgery for at least six to twelve months
[15]. Specific to elective surgery, such as the bariatric population, Katkhouda et al recommends
that patients with bare metal or drug eluting stents should not undergo surgery within the
first year of stent placement. If, as determined by a cardiologist, the patient requires dual
therapy longer than one year after stent placement, clopidogrel and other thienopyridines
should be stopped five to ten days preoperatively and restarted ten days postoperatively [12].
The continuation of aspirin through the perioperative period is recommended [12,15]. In
patients undergoing gastric bypass it is recommended to start proton pump inhibitors one
week preoperatively and subsequently continue them through the perioperative period to
minimize the risk of gastrointestinal bleeding upon restarting clopidogrel therapy [12].
Management of valvular heart disease is dependent on the pathophysiology of the valve.
Patients with symptomatic aortic stenosis should have their surgery delayed and undergo
valve replacement prior to non-cardiac surgery. If the patient has severe stenosis but is
asymptomatic the aortic valve should be evaluated with imaging. Patients unwilling or unable
to undergo cardiac surgery for severe aortic stenosis have a 10% mortality rate from non-
cardiac surgery. With mild or moderate mitral valve stenosis, the heart rate must be controlled
during the perioperative period to minimize pulmonary congestion created by decreased
diastolic filling times. Patients with significant mitral stenosis are at risk for heart failure during
the perioperative period. Operative correction of mitral stenosis is not recommended unless
the valvular condition should be corrected to prolong survival and prevent complications that
are unrelated to the non-cardiac surgery [11].
Congestive heart failure (CHF) has been found to be a significant factor in perioperative cardiac
events. The preoperative evaluation must include screening for CHF which can be done with
history and physical exam alone – look for prior history of heart failure, symptoms of parox‐
ysmal nocturnal dyspnea, presence of an S3 gallop, jugular venous distention, peripheral
edema, bilateral rales on lung auscultation and evidence of pulmonary vascular redistribution
on chest x-ray [11]. The Framingham Heart Study identified obesity as an independent risk
factor for the development of heart failure; with the risk increasing by 5% in men and 7% in
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women for every 1 kg/m2 in BMI [16]. The optimal treatment for CHF is determined by
identifying the cause and degree of failure.
Close collaboration with the patient’s cardiologist during the preoperative workup can allow
for a smooth progression through preoperative cardiac testing, while accurately assessing and
optimizing risk factors.
4. Venous
Venous thromboembolic events (VTE) continue to be one of the most significant postoperative
complications after weight loss surgery; the other being staple line leaks and the associated
septic sequelae. Obesity is considered a hypercoagulable state. The odds ratio of VTE is
between 1.97 and 2.39 in those with a BMI greater than 30 kg/m2 [17]. Bariatric surgery has
been also been associated with a hypercoagulable state due to increased levels of clotting
factors during the perioperative period from surgical trauma [18,19]. VTE events are a leading
cause for mortality after bariatric surgery [20]. It is generally recommended that patients
undergoing weight loss surgery receive VTE prophylaxis during the perioperative period.
Postoperative ambulation and lower extremity sequential compression devices are safe and
recommended for all bariatric patients when appropriate. The proper use of chemoprophylaxis
and the preoperative insertion of inferior vena cava (IVC) filters have been controversial.
The identification of deep venous thrombosis is fundamental to preventing further complica‐
tions from clot progression or embolus. The preferred method for evaluation is venous duplex
ultrasound. This study has a sensitivity and specificity of 97% and 94%, respectively, of
diagnosing a proximal lower extremity DVT [21]. Traditionally, many bariatric centers
included this exam as part of the preoperative workup. A five year retrospective review of our
own bariatric patient population revealed that only one of 555 patients (0.2%) was found to
have a DVT on preoperative workup. This patient had a history of a chronic DVT, known prior
to the examination. Our findings coincided with two previous studies which also showed that
no preoperative investigation is needed [22,23]. Based on these finding we do not recommend
routine preoperative venous duplex ultrasound; however, testing may be warranted in
patients with prior history of DVT or significant venous insufficiency.
The preoperative placement of inferior vena cava (IVC) filters has been reported in high risk
bariatric surgery patients. In some institutions, it was routine to have an IVC filter placed in
patients with BMI greater than 55 kg/m2, immobility, venous stasis, pulmonary hypertension,
obesity hypoventilation syndrome, hypercoagulability, and a history of VTE [20]. It was
recommended that patients with BMI greater than 55 kg/m2 undergoing open gastric bypass
undergo placement of IVC filter while those having laparoscopic surgery could forego the filter
placement [24,25]. Recently, however, the routine use of IVC filters has undergone scrutiny.
The Michigan Bariatric Surgery Collaborative (MBSC) published the largest series to date
regarding the efficacy of preoperative IVC filters in gastric bypass patients. They found that
there was no difference in the rates of VTE, serious complications and death or permanent
disability [26]. In the same month, the United States Food and Drug Administration (FDA)
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published an advisory report regarding the use of retrievable IVC filters. They highlighted 921
device related adverse events since 2005. The FDA recommended a judicious approach to
placement and vigilant follow up for prompt removal of IVC filters [27]. This prompted
another study from the MBSC to investigate outcomes in patients treated with IVC filters. They
discovered that patients with IVC filters had worse outcomes than comparable patients
without IVC filters. A significant number of patients with IVC filters were also subjected to
device related complications, such as thrombosis and occlusion, filter migration, contrast
induced nephropathy and incision site infection. They found the rate of DVT and VTE were
significantly higher in patients with IVC filters, odds ratios 2.7 and 3.3, respectively. Further‐
more, there was no difference in the rates of pulmonary embolus between the groups. They
concluded that IVC filters do not reduce the risk of pulmonary embolism in high risk bariatric
surgery patients and that their use should be discouraged in bariatric surgery patients [28].
Chemoprophylaxis is generally achieved with subcutaneous injections of unfractionated
heparin (UFH) or low molecular weight heparin (LMWH). Since patients are most susceptible
to venous stasis during the induction of anesthesia, the first dose of chemoprophylaxis should
be given preoperatively [29]. Our patients receive 5,000 units of unfractionated heparin
administered subcutaneously immediately prior to entering the operating room. All patients
are also treated with bilateral lower extremity sequential compression devices, which are
placed prior to induction of anesthesia. This combination of chemical and mechanical pro‐
phylaxis has been shown to limit the development of deep venous thrombosis and bleeding
complications [22]. Dosages and frequency vary among the different formulations of low
molecular weight heparinoids, as does their method of action. A recent literature review
concluded that there are three “standard regimens” for chemoprophylaxis of VTE – UFH 5000
units 2 – 3 daily, LMWH 30 mg twice daily, 40 mg once daily or weight adjusted LMWH [30].
The authors concluded that there was no difference in the rate of VTE among the different
regimens, but the use of weight adjusted dosing increased the risk of major bleeding.
Patients with a history of heparin induced thrombocytopenia (HIT) type 2 present a unique
challenge in VTE prophylaxis. This population has not been studied in bariatric surgery;
however, VTE prophylaxis in the orthopedic population with HIT type 2 is accomplished by
the use of desirudin administered subcutaneously [31]. More investigation is needed to
recommend this medication usage beyond the specialty of orthopedics.
5. Pulmonary
Obesity related impairment of respiratory function is caused by mechanical restriction of
adequate ventilation. The increased adipose tissue reduces diaphragmatic excursion, chest
wall expansion and oropharyngeal patency. Obesity is also a risk factor for airway disease and
there is a 50% higher incidence of severe asthma in obese patients when compared to normal
controls [32,33].
A  reduction  in  the  expiratory  reserve  volume  (ERV)  is  the  most  commonly  identified
abnormality on spirometry. Both body mass index and body fat distribution contribute to
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the degree of decrease in ERV. Hamoui et al has shown that in patients undergoing open
duodenal  switch  procedures  there  is  a  relative  risk  of  2.29  to  develop  postoperative
complications for every 10% decrease in percent of predicted value of vital capacity (VC).
They  also  found  that  patients  with  a  VC  of  less  than  80%  of  predicted  have  a  54.5%
prevalence of postoperative complications [34].
The increased rate of complications was also found in laparoscopic bariatric surgery. In 2013,
van Huisstede et al prospectively examined their patients undergoing laparoscopic gastric
bypass and laparoscopic sleeve gastrectomy. Among the 485 patients studied, they found
patients with airflow obstruction (FEV1/FVC < 70%) or airflow reversibility (change in FEV1 >
12%) after administration of a bronchodilator, had an increased risk of postoperative compli‐
cations with an adjusted odds ratio of 2.9 [35]. They recommend spirometry be done routinely
on all patients being evaluated for bariatric surgery. The authors of this chapter follow these
recommendations and routinely evaluate all patients with preoperative pulmonary function
tests.
As pulmonary function tests are often abnormal in obese patients, the causes for abnormality
must be identified and optimized prior to surgery [34]. Smoking is a common entity which
significantly impacts pulmonary function therefore smoking cessation is an essential compo‐
nent of the preoperative assessment. In a study of over 300,000 patients from the Nationwide
Inpatient Sample database smoking was identified as an independent factor associated with
a greater incidence of acute respiratory failure after bariatric surgery [36]. Smoking has also
been shown to be an independent predictor of increased hospital length of stay. Current and
past smokers have been shown to require four and one days longer in the hospital, respectively,
than patients that never smoked [37]. Nicotine, in all forms, is known to have vasoconstrictor
properties. This may add to the microvascular disease caused by smoking which has been
reported to increase the incidence of marginal ulceration and gastrointestinal anastomotic
dehiscence [38,39]. It is our recommendation to not offer surgery to patients who are current
smokers and to those using a nicotine replacement in an attempt to quit smoking. It is our
practice to require smoking cessation to minimize the above mentioned morbidities.
Obstructive sleep apnea (OSA) is a condition in which the upper airway periodically becomes
narrowed or obstructed during sleep and results in reduction or cessation of breathing during
sleep. The reduction in airway caliber is due to the sleep induced loss of muscle tone in the
soft tissues of the oropharyngeal airway. Obstructive sleep apnea is found in 38 – 88% of
morbidly obese patients [40]. There are many screening tools available to the bariatric surgeon
to identify patients at risk for having OSA. The Epworth Sleepiness Score, the Maintenance of
Wakefulness Test, the Berlin Questionnaire and the STOP-BANG Questionnaire are designed
to quickly asses if a patient should be screened further. The definitive diagnosis of OSA is made
with an overnight polysomnography. The test measures the number of hypopnea (30% or
greater decrease in airflow for at least 10 seconds followed by an arousal and/or 3% oxygen
desaturation) and apnea (complete or near complete cessation of airflow for at least 10 seconds
followed by an arousal and/or 3% oxygen desaturation) events and results with an ‘apnea
hypopnea index’, which is classified to the severity of the sleep apnea [41]. Nonoperative
treatment of OSA is achieved with non invasive positive pressure ventilation in the form of
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continuous positive airway pressure (CPAP) or bi-level positive airway pressure (Bi-PAP).
Many patients receive the diagnosis for the first time during the preoperative work up for
bariatric surgery. These patients should be allowed to adapt to the device prior to undergoing
surgery. With regards to anastomotic integrity, the use of CPAP has been proven to be safe
after roux-en-y gastric bypass [42]. In order to maximize compliance, patients should bring
their own machine and mask to the hospital. Although the use of CPAP or BiPAP is recom‐
mended in the postoperative setting, its omission has also been proven safe provided the
patient is an a monitored setting with aggressive pulmonary physiotherapy [40].
In addition to OSA, patients with super morbid obesity can have pulmonary derangements
while awake; this is termed obesity hypoventilation syndrome (OHS). More specifically,
obesity hypoventilation syndrome manifests with daytime hypercapnia with PaCO2 > 44 mm
Hg or 6 kPa, elevated hematocrit, and sleep disordered breathing. These patients are at high
risk for pulmonary complications and VTE [40]. Obesity hypoventilation syndrome occurs in
11% of patients with OSA and in 8% of bariatric surgical patients [43]. Patients with OHS have
severe upper airway obstruction, impaired respiratory mechanics, blunted central respiratory
drive and increased incidence of pulmonary hypertension. The diagnosis of OHS is also made
with polysomnography. The treatment of OHS is similar to OSA in that positive airway
pressure and supplemental oxygen are used to facilitate adequate respiration.
We reviewed our patient database and found that approximately 85% of patients had undiag‐
nosed obstructive sleep apnea with 51% of patients having severe sleep apnea. In the lower
BMI range (35-39.9 kg/m2) our population showed 92% prevalence of OSA. There was a 100%
prevalence of obstructive sleep apnea in those with a BMI greater than or equal to 60 kg/m2.
Based on these results, we can see that BMI does not correlate with the presence of OSA. In a
larger study of 2,458 patients, 509 patients underwent polysomnography within one year prior
to bariatric surgery. In this population 80.7% of patients were found to have obstructive sleep
apnea and 35.5% of these patients had severe sleep apnea [44]. Although some authors advise
that polysomnography should only be used if the patient exhibits symptoms of OSA or OHS,
we recommend that all patients be actively evaluated with polysomnography in the preoper‐
ative period. If found to have sleep apnea, the patients are started on positive pressure
ventilation by mask, at the settings recommended, for several weeks prior to surgery. On the
day of the surgery, the patient is instructed to bring their machine to the hospital and the
machine is routinely used, starting in the recovery room.
6. Anesthesia
The anesthesia preoperative assessment is the culmination of all consults pertinent to the
optimization of the physiological status of the patient. Provided that major cardiopulmonary
issues, cerebral, and metabolic derangements have been addressed, the anesthesiologist
should be able to proceed with the surgery in a controlled and safe manner. As the preoperative
optimization of these organ systems have been addressed previously in this chapter, the focus
of the anesthesiology section will be intravenous access, blood pressure monitoring, aspiration
risk, and airway management on induction of anesthesia.
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Peripheral intravenous access in the bariatric patient may be difficult. The anesthesiologist
should be prepared to use ultrasound guided techniques or central venous access placement
in patients where intravenous access is difficult. Arterial line placement may be utilized when
an appropriately sized blood pressure cuff may not reflect accurate readings secondary to the
conical shaped arms in this population [45]. The possibility of central line placement preop‐
eratively should be discussed with the patient prior to going into the operating room.
Airway  management  during  anesthesia  induction  may  be  challenging  in  the  bariatric
population.  BMI ≥ to 40 kg/m2  has been associated with significant airway management
challenges.  Some institutions have mandated having an attending and one other experi‐
enced anesthesia provider (attending, an anesthesia resident with floor intubation creden‐
tialing,  or  CRNA available  for  intubation  in  this  population).  Due  to  excess  soft  tissue
related to the anatomy, face mask ventilation of the morbidly obese patient may be difficult.
Increased BMI and a  history  of  OSA also  increase  the  possibility  of  difficult  face  mask
ventilation  [46].  When  a  Mallampati  3  or  4  score  is  assessed,  there  has  been  increased
difficulty in intubation, see figure 1 [47].
Figure 1. Mallampati Classification and Laryngoscopic View Grades.
Positioning of the bariatric patient in the supine position, as seen in figure 2, such that the
external auditory meatus is in line with the sternal notch, known as ramping, is recommended
[48]. A recent study demonstrated that in the morbidly obese population undergoing bariatric
surgery, when using the “ramping” position, there was no correlation between difficult direct
laryngoscopy and OSA in Mallampati 1 and 2 classifications. Patients with a BMI of 35kg/m2
have been associated with a greater than 6 fold increase in difficult direct laryngoscopy. Neck
circumference over 40 cm has also been implicated in difficult direct laryngoscopy [49].
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In addition to ventilation and intubation concerns, aspiration risk must be considered. It
has been reported that  the gastric  fluid of  morbidly obese patients  is  more voluminous
and of lower pH than that of the leaner patients [50]. These patients can be considered for
rapid  sequence  induction,  a  technique  for  inducing  a  patient  without  ventilation.  This
technique may expose the anesthesiologist to a greater chance of airway failure. Neutrali‐
zation of gastric acid with clear antacid solutions such as sodium citrate can be prophylac‐
tically given preoperatively.
There are many adjunct airway devices available to assist in the intubation of a challenging
airway. The advent of video laryngoscopy, a plethora of supraglottic airways and flexible fiber
optic intubation has provided multiple modalities and techniques for intubation of the
challenging airway.
When assessing the airway of the bariatric patient, a preoperative plan for securing the airway
safely is invaluable. The American Society of Anesthesiology (ASA) Difficult Airway Algo‐
rithm gives several pathways for the management of the difficult airway, whether the patient
is awake or asleep, see figure 3 [51].
If the anesthesiologist’s evaluation raises doubt in the ability to safely manage the airway,
awake intubation should be undertaken [52]. It is also important to remember that BMI alone
does not predict the probability of a difficult intubation. Preparedness, vigilance and commu‐
nication with the surgeon will result in a favorable patient outcome.
Figure 2. Ramping position.
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Figure 3. Difficult Airway Algorithm.
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7. Endocrine
Evidence is accumulating that suggests obesity is closely related to endocrine disorders, some
at a subclinical level. Obesity has been found to be associated with type 2 diabetes mellitus
(T2DM) and hypothyroidism [53,54].
Management of T2DM is important during the perioperative period. Targets have been
established by the American Association of Clinical Endocrinologists, The Obesity Society and
the American Society for Metabolic and Bariatric Surgery for preoperative glycemic control
which may be associated with improved outcomes, see table 1 [53].
• Hemoglobin A1c of 6.5 – 7.0 % or less
• Fasting blood glucose level of less than or equal to 110 mg/dL
•2-hour postprandial blood glucose concentration of less than or equal to 140 ml/dL
Table 1. Recommendations for preoperative glycemic control
Optimal glycemic control should be achieved preoperatively, as patients with an elevated
preoperative hemoglobin A1c are found to have a higher incidence of postoperative compli‐
cations. A hemoglobin A1c level greater than 8% increases the risk of wound infection and acute
renal failure postoperatively. An elevated A1c in the preoperative setting also increases the
likelihood of elevated blood glucose in the postoperative setting and decreases the rate of
resolution of T2DM after bariatric surgery [55]. Preoperative control can be achieved with a
combination of diet modification, weight loss and pharmaceuticals.
Hypothyroidism is a known cause of obesity; however, de novo thyroid dysfunction has been
observed in obese patients. It has been suggested that subclinical hypothyroidism is associated
with obesity [54]. In some patients, the TSH level has been shown to return to normal levels
after significant weight loss, however the outcome is not universal. The ASMBS does not
recommend routine screening for primary hypothyroidism in the obese patients, however
many bariatric programs require such preoperative screening in keeping with the NIH
guidelines to ensure there is no organic cause to the obesity [53,56].
8. Gastrointestinal
Obesity is a risk factor for gastroesophageal reflux disease, erosive esophagitis, and esophageal
adenocarcinoma [57]. The presence of gastrointestinal diseases has an effect on the type of
bariatric procedure, which can be recommended for a patient and may require treatment prior
to weight loss surgery. In addition, after surgery, the restrictions and rearrangement of the
alimentary tract can limit evaluation and surveillance options. There are many modalities for
assessing the gastrointestinal tract in the preoperative setting.
The American Society for Gastrointestinal Endoscopy (ASGE) recommends an upper endos‐
copy be performed in all patients with upper GI tract symptoms and in all patients undergoing
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weight loss surgery [58]. Preoperative esophagogastroduodenoscopy has been found to reveal
abnormalities in 46 to 90% of patients, with 62% having clinically significant findings. In our
practice, all patients being evaluated for bariatric surgery undergo upper endoscopy. How‐
ever, a five year, internal review of 555 patients has shown 98% of our patients had positive
findings on routine upper endoscopy yet the findings did not cause a delay or impact on the
choice of surgical procedure – questioning the clinical significance of the findings.
During endoscopy tissue biopsies should be obtained to evaluate for H. pylori. If the bacterium
is isolated, eradication with one of several standard regimens is recommended. Recently, there
has been growing support for non-invasive testing for H. pylori in an effort to reduce costs
associated with preoperative testing [59]. One potential algorithm for non-invasive testing
involves screening patients with serum H. pylori test and treating the patient if it is positive.
In either case, proof of eradication should be obtained, typically via urea breath test. Recently
published data indicates that preoperative H. pylori status does not increase the risk for
marginal ulcer or stomal stenosis post roux-en-y gastric bypass [60].
The World Health Organization (WHO) reports the incidence of gastric cancer is highest in
the western pacific region, which comprises 27 countries including China, Japan, Republic of
Korea, Malaysia, Singapore and the Philippines. The incidence in this region was 521,000 cases
in 2004, greater than 50% of the worldwide incidence [61]. In countries where gastric and other
upper gastrointestinal cancers are more prevalent, the importance of preoperative upper
endoscopy cannot be underestimated. Ultimately, practice patterns should reflect the preva‐
lence of significant findings specific to the patient population being prepared for weight loss
surgery.
As an adjunct to endoscopic examination of the gastrointestinal tract several radiographic
investigations are also considered during the preoperative evaluation for bariatric surgery.
Gastroesophageal reflux disease associated with hiatal hernias is commonly found in obese
patients. Completing a bariatric procedure without recognizing and repairing a hiatal hernia
can potentially lead to worsening of reflux and poor surgical outcomes [62]. In order to identify
a hiatal hernia some surgeons obtain contrast enhanced upper GI series. We do not employ
upper GI series routinely in our preoperative evaluations. Hiatal hernias that are identified on
preoperative upper endoscopy are discussed with the patient for informed consent and
subsequently investigated during the operation. In our experience, clinically significant hiatal
hernias are readily identifiable upon laparoscopic inspection and repaired as indicated.
In our practice we routinely assess the size of the liver prior to surgery by abdominal ultra‐
sound. Greater than 30% of morbidly obese patient show fatty infiltration of the liver [63]. As
an enlarged liver is one of the most common reasons for conversion to an open procedure, it
is our practice to place the patient on a liquid diet for two weeks prior to surgery if hepatic
steatosis is identified [64]. Two weeks of a low energy diet has been shown to decrease liver
size and body fat by greater than 5% [63]. In addition to liver size, the gallbladder is also
evaluated for the presence of stones and wall thickening to suggest chronic gallstone disease.
The management of concurrent gallstones in the morbidly obese patient undergoing bariatric
surgery has been a controversial topic. During the era of open weight loss surgery concomitant
cholecystectomy was recommended for all patients undergoing open gastric bypass [65,66].
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The view on cholecystectomy has changed since the widespread adoption of laparoscopic
bariatric surgery. Addition of cholecystectomy to laparoscopic roux-en-y gastric bypass was
found to add approximately 50 minutes to the operative time and significantly increased
hospital length of stay, 2.69 days versus 4.35 days [67]. A study of 625 patients by D’Hount et
al showed that only 6.9% of patients developed symptomatic gallstone disease post gastric
bypass. The mean time between gastric bypass and cholecystectomy was 17.4 ± 13.1 months
[68]. We do not advocate performing cholecystectomy at the same time as primary bariatric
procedures unless absolutely necessary due to the increased operative time and length of stay.
We do employ the use of ursodeoxycholic acid in the postoperative period to reduce the rate
of gallstone formation in our gastric bypass patients due to the challenge of addressing
choledocholithiasis in this patient population [53].
9. Nutritional
A preoperative nutritional assessment with a registered dietitian is essential when preparing
for surgery. The preoperative nutritional assessment is designed to help the patient recognize
the need for positive lifestyle changes and develop a plan to implement them. This will likely
result in improvement of nutritional status, better management of nutrition-related comor‐
bidities and development of habits that will positively influence weight loss outcomes and
maintenance [69]. It is also a time to thoroughly review the postoperative diet with the patient,
which includes gradually advancing the diet in terms of texture and variety, including exercise
on a regular basis, staying hydrated with appropriate fluids, and adhering to the recommended
vitamin and mineral regimen. In this section, we will discuss preoperative behavior changes
that could potentially affect long-term outcomes.
A thorough preoperative nutritional assessment should include review of anthropometrical
data, weight history, past diet history, medical history, available laboratory values, psycho‐
logical history (including history of eating disorders), social history, substance abuse history,
nutrition-focused physical findings (such as poor dentition), dietary intake, physical activity,
and psychosocial factors that affect weight loss [70]. When discussing dietary intake with a
patient, it is important to determine how many meals the patient includes on a daily basis,
whether or not the patient snacks all day (i.e. grazing, picking, nibbling), if the patient has a
past or current history of eating disorders, macronutrient and micronutrient composition of
frequently chosen foods and beverages, and alcohol intake [69]. Preoperative nutrition
counseling should be adapted to each individual patient.
Patients' eating habits and exercise patterns are determined by a variety of environmental,
psychological, biological, and social factors. Environmental factors include work schedule,
occupation, socioeconomic status, and family traditions. Psychological factors include low self-
esteem, feeling a lack of control in life, feeling inadequate, depression, anxiety, stress, and
loneliness. Social factors include cultural glorification of the "perfect body", society placing
more value on physical appearance and not on inner qualities, and stress related to size/body
shape due to past discrimination [71]. Biological and biochemical factors are still being
Preoperative Evaluation of Bariatric Surgery Patients
http://dx.doi.org/10.5772/58605
17
explored, but recent research has shown that gastrointestinal hormone imbalance can affect
hunger and appetite [72]. It is important for patients to understand that, regardless of the
reasons behind them, current eating patterns will likely result in poor weight loss, weight
regain, and malnutrition after surgery. Preoperative nutritional counseling should focus on
addressing these behaviors, working with the patient to avoid or manage them, and having
the patient demonstrate compliance with the recommended changes.
Two environmental factors that are of particular concern are socioeconomic status and shift
work. In low-income areas, access to nutrient-rich foods is oftentimes limited [73]. Planning
grocery lists and affordable recipes with a low-income patient would be an appropriate
intervention. Having the patient complete food logs that show more meals are prepared in the
home with the ingredients purchased from the grocery list will demonstrate that he/she is able
to incorporate this healthy behavior on a routine basis, thus lowering the risk of postoperative
malnutrition. Obesity is frequently seen in people who work overnight shifts or who have
alternating shifts and late shift workers have higher rates of weight gain after starting their
jobs [74,75]. In our practice, patients report that they feel it is inappropriate to eat in the middle
of the night. This often results in eating large portions before work and after work, as well as
grazing on empty-calorie foods during the night. Working with the patient to break the idea
that it is "bad" to be eating in the night is key when it comes to changing behaviors to positively
affect weight loss and nutrition status postoperatively. Including regularly-timed meals and
snacks that include an appropriate balance of protein, carbohydrates, and fat will set the patient
up for long-term success.
Sometimes, patients have a past or present history of eating disorders that likely require
additional psychological counseling in addition to nutritional counseling. Hence, coordination
between the dietitian and the mental health care provider is critical. There is a fair amount of
literature regarding Binge Eating Disorder (BED), subdiagnostic BED, and night eating
syndrome in the preoperative setting, most of which states that psychological counseling is
encouraged for patients that have either been diagnosed with an eating disorder or show
tendencies towards one [76-78]. Some studies have suggested that patients with preoperative
BED might be more inclined to graze after surgery, thus sabotaging weight loss, while other
research suggests that prior history of eating disorders is not a predictor of poor outcomes
following bariatric surgery [78,79]. Emotional eating is technically not considered an eating
disorder, but its presence oftentimes has psychological roots. Some case studies have shown
that cognitive behavioral therapy can help manage emotional eating both pre and postopera‐
tively [80]. The only eating disorder that is a contraindication to bariatric surgery is active
bulimia nervosa, but ultimately it is up to the multidisciplinary bariatric surgery team to decide
if they feel a patient's past history of eating disorders could potentially jeopardize the patient's
health [78]. Bariatric surgical teams should keep in mind that the psychological evaluation is
not the only setting in which a patient might disclose episodes of disordered eating. Questions
inquiring about eating disorders should be included in the nutrition evaluation, and if during
subsequent visits the patient suggests that he or she has tendencies towards these behaviors,
the patient should undergo psychological treatment before proceeding with surgery.
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Most commonly, the areas dietitians will find they need to counsel patients on before surgery
include portion control, macronutrient and micronutrient composition of frequently chosen
foods, skipping meals, and physical activity. Dietitians use various tools to help assess a
patient's food and beverage intake, including the 24-hour recall and food frequency question‐
naires. When counseling patients preoperatively, it is important to put the emphasis on how
dietary and lifestyle changes positively affect long-term weight maintenance. Adhering to
portion control before surgery will likely lead to preoperative weight loss, resulting in a lower
weight 24 months after surgery. It will also help patients maintain their weight loss over the
long term. Patients often state they are limited in food choices postoperatively. Developing a
menu before surgery that includes a variety of soft proteins (e.g. low-fat dairy, beans, nut
butters, fish), whole grains, fruits, vegetables, and healthy fats will empower patients to try
new foods and recipes after surgery that are appropriate for the texture that they are able to
tolerate. This will help stave off taste fatigue and provide a more nutritious diet as they are
able to include more solid, textured foods [81]. Patients should also be working towards
eliminating intake of sugar-sweetened beverages in the preoperative period and including
mostly water and sugar-free beverages. While skipping any meal is discouraged, observational
studies highlight that eating breakfast regularly can be an effective tool for weight manage‐
ment [82]. Regularly eating breakfast is associated with lower BMI in adults, and inclusion of
whole grains, fruit, and low-fat dairy may be related to appetite control and blood glucose
regulation, both contributing factors to obesity [83]. Patients often have the misconception that
skipping breakfast will lead to eating fewer calories in the day, when in fact, skipping breakfast
can lead to cravings of high-calorie foods later in the day [84]. Therefore, patients should be
encouraged to include breakfast daily in order to better maintain weight loss after surgery.
Lastly, physical activity is consistently cited as a predictor of weight loss maintenance [85].
Despite being aware that physical activity has health benefits, barriers to exercise still remain.
They include inability to self-motivate, lack of encouragement from family and friends, time
constraints, low self-efficacy, fear of being injured, recent injury, and lack of resources (i.e. no
sidewalks or parks in neighborhood) [86]. Overcoming barriers to exercise will likely take a
team approach, including the dietitian, psychologist, and possibly a physical therapist. The
patient should be encouraged to begin a rather simple exercise program that takes into account
reservations about exercise and physical limitations. We often see that as patients begin
exercise programs, they are hesitant and resistant; however, as their self-esteem improves and
physical activity becomes less taxing on the body, they build upon the program and welcome
the exercise. They report having more energy, looking forward to the time by themselves, and
overall mood improvement. Walking for as little as 5 minutes per day can often lead to walking
for 30 minutes 3-4 times per week over a 3-month span.
With regard to micronutrients, it is estimated that 2 billion people worldwide suffer from
vitamin and mineral malnutrition despite adequate calorie intake. In the United States greater
than 75% of people are taking in below the daily recommended value of vitamins A, D and E.
Additionally, 50 to 75% of Americans are also not taking enough vitamin C [87]. These
deficiencies are also seen in patients presenting for weight loss surgery. Obese patients are at
increased risk for nutritional abnormalities in the preoperative setting; they have been found
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to be deficient in thiamine, folate, zinc, iron, ferritin, selenium, beta-carotene, magnesium, and
vitamins A, B-12, C and D [88-92]. Vitamin D levels are also affected by latitude and this should
also be taken into consideration when screening and supplementing these deficiencies. It is
imperative to evaluate and supplement all nutritional deficits prior to surgery to prevent
deficiencies which can be significantly more difficult to correct in the postoperative period.
These micronutrients should be supplemented in the preoperative setting and monitored to
ensure normal values before surgery. All patients undergo postoperative monitoring to guide
supplementation after bariatric surgery with frequent regularly scheduled blood tests.
As bariatric surgery becomes a safer, more popular, and more accepted form of weight loss
amongst health professionals, it is clear that a thorough preoperative nutritional assessment
and consistent preoperative follow-up with the dietitian is essential for the patient to lose an
appropriate amount of weight, avoid malnutrition, and to maintain the weight loss hopefully
for life [93-95]. Whether the dietitian has 6 weeks or 6 months to work with the patient
preoperatively, the main focus should be to build the foundation for a healthier lifestyle and
better eating habits.
10. Psychological
The fight against obesity has many fronts. Simply reducing the capacity or absorption of the
gastrointestinal tract will not have long lasting effects on weight if the psychosocial aspects of
the disease are not addressed. An essential part of the preoperative evaluation is a psycho‐
logical clearance [96]. The psychosocial and behavioral evaluation is geared to confirm the
patient’s ability to incorporate nutritional and behavioral changes before and after bariatric
surgery. The psychological investigation is also used to identify cognitive, environmental, or
psychiatric contraindications prior to surgery and to offer treatment for any disorders
identified [97]. The obese adult population in the United States has been found to have higher
incidence of major depression, bipolar disorder, generalized anxiety and panic disorder [98].
Intervening in these disease processes can enhance postoperative weight reduction; however,
no definitive significant improvement in weight loss has been shown [53].
The interview consists of a standard psychological evaluation, evaluation of the patient’s
appropriateness  for  surgery,  an  assessment  of  eating  behavior,  stress,  coping  mecha‐
nisms,  and social  support.  It  is  also  used to  confirm that  the  patient  has  the  ability  to
consent  and  evaluate  all  the  potential  risks  and  possible  benefits  to  surgery  [96].  The
psychosocial evaluation should be performed by a credentialed expert in psychology and
behavior  modification  for  all  patients.  Screening  for  eating  disorders  can  involve  using
standardized assessments, see table 2 [96].
Mental illnesses and eating disorders identified during the screening process are not necessa‐
rily contraindications to surgery [99]. Their optimization is key for a durable and satisfying
outcome. The bariatric surgeon should be aware that the patient may exhibit impression
management during the preoperative psychological evaluation. This is done by purposefully
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minimizing psychological symptoms to receive a recommendation to proceed with surgery
from the mental health professional. It is recommended that mental health professionals use
measures to assess for impression management, as this will allow for proper preoperative
treatment and minimize postoperative surprises [97].
11. Education
The process towards obtaining successful results after bariatric surgery begins during the
preoperative period. The algorithm of care is a multi step process and requires full participa‐
tion of both the practitioners and the patient. The ability to follow the plan of care and manage
lifestyle changes required for successful weight loss depends on how well the patients are
prepared prior to surgery. High patient satisfaction rating has been demonstrated after
instituting a preoperative class for their bariatric patients [100]. Their class covered the
following content: presurgery appointments, preparing for surgery, postoperative procedures,
pain management, activity levels, wound care, nutrition, lifestyle changes and discharge
instructions.
The ASMBS recommends having educational objectives and assessments throughout the
preoperative period. It is suggested that the materials provided to the patients be at a sixth to
eighth grade reading level to maximize comprehension [53]. Multimedia tools are also useful,
however patients should be cautioned against using the internet as an information source as
there is a high degree of bias, conflicting statements and out of date information [100]. The
main goal of preoperative education is to provide information needed for informed consent,
prepare the patient for the required lifestyle change and to establish realistic expectations
regarding potential weight loss and quality of life improvements.
12. Functional status
A crucial component of the preoperative evaluation includes assessing the patient’s ability to
complete the activities of daily living. Bariatric patients have a high rate of comorbid condi‐
• Eating Disorder Examination Questionnaire
• Cleveland Clinic Behavioral Rating System
• Millon Behavioral Medicine Diagnostic (MBMD) (Pearson, San Antonio, Texas, USA)
• Alcohol Use Disorder Identification Test – Consumption (AUDIT-C)
• Beck Depression Inventory – II (BDI-II)
• Beck Anxiety Inventory (BAI)
• Multidimensional Health Locus of Control Scale
• Overeater’s questionnaire
Table 2. Mental health assessment tools prior to weight loss surgery
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tions, some of which can cause physical limitation. Morbidly obese patients are also limited
by their body habitus and weight related pain; this is especially true in the super morbidly
obese patients. The limitations in mobility can impede on preoperative weight loss, cause
psychological stress and limit access to care [101]. Preoperative functional status should be
evaluated as it has been shown to be the strongest predictor for postoperative in hospital
morbidity and mortality [102]. Our previously published data revealed that a completely
dependent patient was 27 times more likely to experience mortality after bariatric surgery. The
information gained from investigations into the patient’s functional status is shared with the
patient and risks, benefits and alternatives are discussed with the ability to offer a reasonable
prognosis of the postoperative period.
Preoperative exercise has been found to reduce surgical  complications,  facilitate healing,
achieve  the  mindset  needed  for  positive  behavior  changes,  and  augment  the  rate  of
increased  postoperative  physical  activity  [103].  The  ASMBS  suggests  exercise  for  20
minutes, three to four days a week is sufficient to achieve these results [104]. Most bariatric
surgery patients have sedentary lifestyles and low physical activity level. King and Bond
describe a five step process to providing physical activity counseling to patients undergo‐
ing weight loss surgery [103].
The first step is to assess the patient’s knowledge, beliefs and values regarding exercise along
with prior and current levels of physical activity. The potential barriers successful implemen‐
tation of a physical activity program should also be investigated at this point. Prior to begin‐
ning a physical activity program, the patients with current or a history of exercise intolerance
should be referred to a cardiologist for proper exercise testing. Aside from cardiopulmonary
restrictions to exercise, patients should be assessed for physical limitations such as sensory,
balance and gait abnormalities – all of which can increase the risk of injury.
The second step is to advise the patient on the benefits of physical activity and develop realistic
expectations. Strategies to increase safety and decrease barriers should be established. The
patients should be taught how to gauge the level of intensity using the talk test or by measuring
their own heart rate.
The thirds step is to come to a mutual agreement with the patient regarding their short,
intermediate and long term physical activity goals. The goals should not be end results such
as weight loss or maximal activity, but rather, specific goals regarding the frequency, duration
and type of physical activity performed. It is recommended that the clinician set one goal that
the patient has a high likelihood of achieving to boost confidence and encourage the patient
to continue increasing their level of physical activity.
The fourth step is to assist the patient in achieving the goals by providing the patient printed
materials and other resources that support self monitored physical activity. Such items include
diaries, pedometers and a list of safe walking paths or fitness facilities. Patients who need a
high level of encouragement or guidance, and those with significant barriers should be referred
to professional personal trainers or other exercise professionals to achieve the best results.
The final step is to arrange for follow up and monitoring to answer questions and provide
reinforcement. The patient and clinician should not be discouraged if the level of physical
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activity is not immediately increased after one meeting. It may take many visits for the patients
to overcome their barriers and begin a physical activity plan. The healthcare provider should
remain vigilant and provide continual counseling to the patient.
13. Conclusions
The preoperative evaluation of the bariatric surgery patient requires a multidisciplinary
approach, ultimately coordinated by the surgeon. There are many details to which attention
must be paid including medical, nutritional and psychological aspects in an effort to fully
evaluate the patient as a whole. This multi faceted approach is one of the factors which have
allowed bariatric surgery to become a safe and effective method for weight loss and comor‐
bidity amelioration. These evaluations may reveal problems which should be addressed before
surgery to ensure safety and success in the postoperative period. These assessments offer the
best way to prepare and counsel a patient for these life altering operations and provide a
reasonable basis of expectation on the part of the surgeon and the patient. Many of the learning
points incorporated into the preoperative evaluation of bariatric patients can potentially be
applied to other disciplines.
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